FGEN – fibrogen, inc (US:NASDAQ)
Stock Stats
News
Global Duchenne Muscular Dystrophy Drugs Market Set to Reach $ 5.5 Billion by 2032, With a CAGR of 10.17% Driven by New Product Approvals, Launches, and a Favorable Landscape [Yahoo! Finance]
FibroGen to Report First Quarter 2024 Financial Results [Yahoo! Finance]
FibroGen to Report First Quarter 2024 Financial Results
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology A
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology
Form ARS FIBROGEN INC For: Dec 31
Form DEFA14A FIBROGEN INC
Form DEF 14A FIBROGEN INC For: Jun 05
Form 3 FIBROGEN INC For: Apr 22 Filed by: Adib Deyaa
Form 4 FIBROGEN INC For: Mar 22 Filed by: Wettig Thane
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.